Tags

,

After the company drew negative publicity in March for denying a drug to a child, its stock jumped as that drug has shown promise in treating Ebola.

from NYT > Business Day http://ift.tt/1vRbrrP
via IFTTThttp://ift.tt/eA8V8J http://ift.tt/IP98QF

Advertisements